Clinical trial · Interventional
Virtual Reality and Fatigue Education
The Effect of Virtual Reality and Fatigue Education on Fatigue and Anxiety Levels in Children With Cancer
NCT05774379CI-TRIAL-00064783VRfatiguecompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It was planned to evaluate the effect of distraction intervention with virtual reality and fatigue education on the level of fatigue and anxiety in children with cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Fatigue | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| fatigue education | Behavioral | — | UNRESOLVED |
| virtual reality and fatigue education | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- virtual reality and fatigue education
- description
- watching the application by wearing virtual glasses for 3 days and Providing training on fatigue to all children (1 session, average 45 minutes) (using role-play, exercise, games, coloring books and activity materials)
- interventionNames
- Device: virtual reality and fatigue education
- type
- EXPERIMENTAL
- label
- fatigue education
- description
- Providing training on fatigue to all children (1 session, average 45 minutes) (using role-play, exercise, games, coloring books and activity materials)
- interventionNames
- Behavioral: fatigue education
Primary outcomes (2)
- measure
- fatigue
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 7 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Be between 7-18 years old * Inpatient chemotherapy treatment for more than three days * 4 weeks over the time of diagnosis (not in the induction phase) * Having a hemoglobin level above the criteria for transfusion of blood products (8 mg/dl for hematological malignancies, below 7 mg/dl for oncological malignancies). * The child voluntarily agrees to participate in the study and consent is obtained from the child and parent Exclusion Criteria: * Being in terminal period * undergoing a surgical operation * Unwillingness to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.